Tradestie Institutional Equity Comparison Engine

PEN vs NMTC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PEN Overall Edge

PEN Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Penumbra, Inc. (PEN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PEN trades at 53.1x Forward P/E with 12.1% operating margin (+15.6% YoY revenue) versus NMTC at N/M Forward P/E and -63.4% operating margin (+16.3% YoY). In options structure, PEN sits in UNCLASSIFIED (96th %ile IV; Dealer Gamma Walls on Pro) against NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PEN
PEN 53.1x vs NMTC N/M Fwd P/E
Growth & Margin Winner PEN
Op Margin 12.1% vs -63.4% ยท YoY +15.6% vs +16.3%
Momentum & Technical Winner PEN
1Y +12.7% vs +3.5% ยท 52W Pos 50% vs 2%
Options & Structure Winner PEN
UNCLASSIFIED (96th %ile IV) vs UNCLASSIFIED (N/A IV)
PEN NYSE
Penumbra, Inc.
Surgical & Medical Instruments & Apparatus
$319.12
-0.28% 1D
Market Cap $12.6B
1M Return -1.8%
1Y Return +12.7%
Forward P/E 53.1x
Unified AI Score
52.2 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 63.0 Mom 46.0
NMTC NASDAQ
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap $6.1M
1M Return -33.46%
1Y Return +3.49%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 60.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PEN +12.7% NMTC +3.49% Spread: +9.21 pp (PEN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PEN Revenue NMTC Revenue PEN Op. Margin NMTC Op. Margin Margin Edge
FY2018 $440M N/A -0.2% N/A PEN
FY2019 $550M N/A 8.7% N/A PEN
FY2020 $560M N/A -6.9% N/A PEN
FY2021 $750M $0M -1.0% -5735.9% PEN
FY2022 $850M $0M 0.7% -5860.2% PEN
FY2023 $1.06B $0M 6.9% -612.3% PEN
FY2024 $1.19B $0M 0.8% -344.3% PEN
FY2025 $1.40B $10M 13.5% -46.5% PEN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PEN (9) vs NMTC (1)
Institutional Metric PEN NMTC Criterion Row Winner
Market Capitalization Scale $12.6B $6.1M Larger Scale PEN
Trailing P/E Ratio Valuation 80.6x N/M Lower Multiple PEN
Forward P/E Ratio Valuation 53.1x N/M Lower Multiple PEN
Revenue Growth (YoY) Growth +15.6% +16.3% Higher Growth NMTC
Operating Margin (TTM) Profitability 12.1% -63.4% Higher Margin PEN
Net Profit Margin Profitability 10.1% -59.7% Higher Margin PEN
Return on Equity (ROE) Capital Efficiency 10.7% -124.7% Higher ROE PEN
52-Week Range Position Momentum 50% ($277โ€“$362) 2% ($1โ€“$5) Stronger Trend PEN
Beta / 30D Volatility Risk Regime 0.10ฮฒ ยท 10% Vol 1.55ฮฒ ยท 105% Vol Lower Realized Risk PEN
Unified Institutional Score Composite Signal 52.2 / 100 (HOLD) 45.5 / 100 (HOLD) Higher Composite PEN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PEN vs NMTC Buy Guide
PEN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 96th %ile
IV Regime Extreme (>80th %ile)
Live PEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NMTC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NMTC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PEN nor NMTC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.